Abstract
Objectives:SLE is an autoimmune disease characterised by aberrant lymphocyte activation and autoantibody production. This study provides an in-depth preclinical and clinical characterisation of the treatment effect of cenerimod, a sphingosine-1-phosphate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have